Similar articles

• [Clinical results of the associated use of a thymus extract (Leukotrophin) as an anti-leukopenic agent in radiotherapy and chemotherapy of neoplastic diseases].

  Banfi F, Ferrari M, Rusconi A. Banfi F, et al. Minerva Med. 1970 Sep 8;61(72):3818-24. Minerva Med. 1970. PMID: 5454450 Italian. No abstract available.
• [Study of the action of a thymus extract on leukopenia caused by therapeutic irradiation].

  Di Guglielmo L, Coucourde F. Di Guglielmo L, et al. Minerva Med. 1970 Sep 8;61(72):3805-10. Minerva Med. 1970. PMID: 5454448 Italian. No abstract available.
• [The protective action of a thymus extract on hematopoiesis in patients treated with intense radiation and cytostatic therapy].

  Orecchia C, Ardizzone L, Sigaudo F. Orecchia C, et al. Minerva Med. 1970 Sep 8;61(72):3825-36. Minerva Med. 1970. PMID: 5454451 Italian. No abstract available.
• [Colony-stimulating factors. Therapeutic applications].

  Kusminsky GD, Koziner B. Kusminsky GD, et al. Sangre (Barc). 1990 Oct;35(5):381-7. Sangre (Barc). 1990. PMID: 2291148 Review. Spanish. No abstract available.
• [Prognosis of leukopenia at the early stages of radio- and chemotherapy for Hodgkin's disease].

  Ivanov SD. Ivanov SD. Vopr Onkol. 2000;46(2):129-35. Vopr Onkol. 2000. PMID: 10853408 Review. Russian. No abstract available.